Cargando…
Neural network analysis of combined conventional and experimental prognostic markers in prostate cancer: a pilot study.
Prostate cancer is the second most common malignancy in men in the UK. The disease is unpredictable in its behaviour and, at present, no single investigative method allows clinicians to differentiate between tumours that will progress and those that will remain quiescent. There is an increasing need...
Autores principales: | Naguib, R. N., Robinson, M. C., Neal, D. E., Hamdy, F. C. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group|1
1998
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2062883/ https://www.ncbi.nlm.nih.gov/pubmed/9683301 |
Ejemplares similares
-
Effectiveness and cost-effectiveness of prognostic markers in prostate cancer
por: Calvert, N W, et al.
Publicado: (2003) -
bcl-2 overexpression combined with p53 protein accumulation correlates with hormone-refractory prostate cancer.
por: Apakama, I., et al.
Publicado: (1996) -
Prognostic marker and target in prostate cancer
por: Lavorgna, Giovanni, et al.
Publicado: (2015) -
Neural networks in experimental high energy physics
por: Bortolotto, C, et al.
Publicado: (1992) -
Predicting High-Grade Cancer at Ten-Core Prostate Biopsy Using Four Kallikrein Markers Measured in Blood in the ProtecT Study
por: Bryant, Richard J., et al.
Publicado: (2015)